NCT07274449 2025-12-10NKThe Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolPhase 1/2 Active not recruiting6 enrolled
NCT02694822 2025-03-17AGEN1884, an Anti-CTLA-4 Human Monoclonal Antibody in Participants With Advanced or Refractory Cancer and Who Have Progressed With PD-1/PD-L1 Inhibitor as Their Most Recent TherapyAgenus Inc.Phase 1/2 Completed89 enrolled 22 charts